Exosome Market Forces > 해외 pr

Exosome-related technologies have been developing rapidly  

over the past few years and substantial growth is expected for  

the market as they get integrated into the fields of liquid biopsy,  

precision medicine and regenerative medicine. 

  In particular, cancer derived exosomes influence the invasive    

potential of cells by regulating angiogenesis, metastasis, and  

immunity, making them an extremely useful source of  

biomarkers for use in cancer detection, diagnosis, and   

therapeutic selection. 

  In May 2017, ExCoBio Inc. raised US $11 million in a Series  

A funding round.  ExoCoBio is a venture-backed startup that  

develops exosome- based cosmeceuticals and  

biopharmaceuticals for skin and tissue regeneration that is  

headquartered in South Korea Companies Mentioned Include:

·        Anjarium Biosciences 

·        Avalon GloboCare Corp. 

·        Beckman Coulter 

·        Capricor Therapeutics 

·        Cavadis B.V. 

·        Cell Guidance Systems 

·        Codiak Biosciences 

·        CosmoBio USA 

·        Creative Medical Technologies Holdings 

·        Exiqon 

·        ExoCoBio Inc. 

·        Exerkine Corporation 

·        Exopharm 

·        Exosome Diagnostics 

·        Evox Therapeutics 

·        Exogenus Therapeutics 

·        Exosome Sciences 

·        Exosomics Siena SpA 

·        Exostemtech Co. Ltd. 

·        Exovita Biosciences 

·        Galen Lab Supplies 

·        Guangzhou Selaira Stem Cell Technology Co., Ltd 

·        HansaBioMed Life Sciences 

·        iZon Science 

·        Kimera Labs 

·        Lonza 

·        Miltenyi Biotec 

·        Norgen Biotek 

·        ReNeuron 

·        RoosterBio 

·        Unicyte AG 

·        VivaZome Therapeutics 

·        ZenBio
 

                                                                                                <BioInformant> 2018. 3.23
 

 URL : https://bioinformant.com/exosome-market-forces/